Consint.AI Series A funding of ₹22 crore (approximately $2.3 million) has officially closed, as publicly reported on 2026-08-06, with BIG Global Investment JSC leading the round alongside participating investors Equanimity Ventures Trust II and Seafund Venture India Scheme I. The Noida-headquartered deeptech company develops AI-powered platforms that help healthcare providers, insurers, and enterprises improve fraud detection, claims processing, and clinical intelligence. The raise marks a significant vote of confidence in vertical AI startups tackling deeply regulated sectors at scale.
Quick Highlights
- Founders: Ashish Chaturvedi, Swadeep Singh, and Rajat Shah
- Lead Investor: BIG Global Investment JSC
- Participating Investors: Equanimity Ventures Trust II; Seafund Venture India Scheme I
- Headquarters: Noida, Uttar Pradesh (Delhi NCR)
- Announcement Date: 6 August 2026
Funding Breakdown
Use of Funds
As publicly reported, Consint.AI will deploy the fresh capital across three core priorities. First, the company plans to strengthen its AI research and enterprise delivery capabilities. Second, it will build a foundational AI model specifically designed for fraud, waste and abuse (FWA) detection across the healthcare, insurance, banking and financial services (BFSI) sectors. This model is intended to power the startup’s flagship platforms — Risk.AI, which identifies fraudulent transactions and assesses underwriting risks, and CIPHR.ai, which standardises structured and unstructured patient health records to support clinical workflows and population health analytics. The company also operates AutoClaim AI for automated claims processing and DocInsight AI for document intelligence.
Funding Timeline
Founded in 2020, Consint.AI previously raised ₹5 crore in a seed round in 2025 from Equanimity Ventures and Seafund. The current Series A of ₹22 crore brings the company’s total disclosed funding to over ₹27 crore, as publicly reported.
Expansion Plans
With this capital in hand, Consint.AI plans to expand its operational footprint across India, the United States, the Middle East and North Africa (MENA), Africa, and Southeast Asia. The company’s forthcoming foundational AI model is expected to further strengthen fraud detection capabilities while supporting insurers, healthcare providers and government health programmes across these new geographies. The platform, which has already assessed more than 100 million transactions and identified over ₹1,000 crore in fraud using more than 500 AI and machine learning models, fine-tuned large language models (LLMs), and over 500 digitised clinical protocols, is positioned to scale its enterprise reach significantly in the next phase of growth.
Significance
The Consint.AI Series A underscores growing investor appetite for deeptech startups that apply specialised AI to high-stakes, regulated industries rather than general-purpose use cases. Healthcare fraud, waste and abuse represent a multi-billion-dollar problem globally, and purpose-built AI platforms with proven transaction-level results — such as those Consint.AI reports — are increasingly attractive to enterprise buyers and institutional investors alike. The entry of BIG Global Investment JSC as lead investor also signals cross-border interest in Indian HealthTech-AI ventures with a demonstrated international market thesis. As publicly reported, the round positions Consint.AI to move from a domestic-first model to a genuinely global AI platform for risk and fraud management.
These details have been verified against multiple publicly available reports as of 2026-08-06.
Stay updated with the latest startup funding news on The Courtroom.
Disclaimer: This report is compiled from publicly available sources and is for informational purposes only; funding figures are as publicly reported and may be subject to change.
